A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection
NCT04100603 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
- Clostridium Difficile
- Clostridium Difficile Infection
- Microbiome
- CDI
Interventions
- OTHER
-
No Intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis
NCT01973465 ·Status: UNKNOWN ·Phase: NA
-
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI
NCT02255305 ·Status: TERMINATED ·Phase: PHASE2
-
IMT for Primary Clostridium Difficile Infection
NCT02301000 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
NCT01372943 ·Status: TERMINATED ·Phase: NA
-
Fecal Microbiota Transplant for Primary CDI
NCT03795233 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Digestive Microbiota Transplant
NCT03606031 ·Status: UNKNOWN
-
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
NCT00304863 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
NCT01259726 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
Fecal Microbiome Transplant
NCT02636517 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
NCT00446355 ·Status: COMPLETED
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients
NCT02200328 ·Status: TERMINATED ·Phase: PHASE4
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
NCT01868373 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
NCT06107569 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Microbiome Analysis of Constipated Versus Non-constipation Patients
NCT04106232 ·Status: COMPLETED
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Transplantation of Fecal Microbiota for Clostridium Difficile Infection
NCT01958463 ·Status: UNKNOWN ·Phase: PHASE3
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED